OBJECTIVE: To determine the changes in cardiovascular risk factors and psychological and physical symptoms that occur during the perimenopause. DESIGN: Cohort study of 541 healthy middle-aged premenopausal women followed up through the menopause. SETTING: General community. PARTICIPANTS: After a baseline evaluation taken at study entry, 152 women ceased menstruating for 3 months (not due to surgery) and were not using hormone replacement therapy, and were reevaluated in a similar protocol (perimenopausal examination); 105 of the 152 were evaluated a third time when they had ceased menstruating for 12 months and were not using hormone replacement therapy (postmenopausal examination). One hundred nine premenopausal women who were repeatedly tested constituted a comparison group. MAIN OUTCOME MEASURES: Levels of lipids and lipoproteins, triglycerides, fasting glucose and insulin, blood pressure, weight, height, and standardized measures of psychological symptoms. RESULTS: Women who became perimenopausal showed increased levels of cardiovascular risk factors, which were similar in magnitude to those experienced by the comparison group of premenopausal women. Perimenopausal women reported a greater number of symptoms, especially hot flashes, cold sweats, joint pain, aches in the skull and/or neck, and being forgetful; reports of hot flashes at the perimenopausal examination were associated with low concentrations of serum estrogens. Menopausal status was not associated with depressive symptoms. Perimenopausal women who became postmenopausal showed a decline in the level of high-density lipoprotein-2-cholesterol (means, 0.53 to 0.43 mmol/L [20.6 to 16.7 mg/dL]) and a gradual increase in the level of low-density lipoprotein cholesterol (means, 3.14 to 3.33 mmol/L [121.3 to 128.8 mg/dL]), whereas symptom reporting declined. CONCLUSIONS: During mid-life, women experience adverse changes in cardiovascular risk factors and a temporary increase in total number of reported symptoms, with no change in depression. Preventive efforts to reduce the menopause-induced increase in cardiovascular risk factors should begin early in the menopausal transition.
OBJECTIVE: To determine the changes in cardiovascular risk factors and psychological and physical symptoms that occur during the perimenopause. DESIGN: Cohort study of 541 healthy middle-aged premenopausal women followed up through the menopause. SETTING: General community. PARTICIPANTS: After a baseline evaluation taken at study entry, 152 women ceased menstruating for 3 months (not due to surgery) and were not using hormone replacement therapy, and were reevaluated in a similar protocol (perimenopausal examination); 105 of the 152 were evaluated a third time when they had ceased menstruating for 12 months and were not using hormone replacement therapy (postmenopausal examination). One hundred nine premenopausal women who were repeatedly tested constituted a comparison group. MAIN OUTCOME MEASURES: Levels of lipids and lipoproteins, triglycerides, fasting glucose and insulin, blood pressure, weight, height, and standardized measures of psychological symptoms. RESULTS:Women who became perimenopausal showed increased levels of cardiovascular risk factors, which were similar in magnitude to those experienced by the comparison group of premenopausal women. Perimenopausal women reported a greater number of symptoms, especially hot flashes, cold sweats, joint pain, aches in the skull and/or neck, and being forgetful; reports of hot flashes at the perimenopausal examination were associated with low concentrations of serum estrogens. Menopausal status was not associated with depressive symptoms. Perimenopausal women who became postmenopausal showed a decline in the level of high-density lipoprotein-2-cholesterol (means, 0.53 to 0.43 mmol/L [20.6 to 16.7 mg/dL]) and a gradual increase in the level of low-density lipoprotein cholesterol (means, 3.14 to 3.33 mmol/L [121.3 to 128.8 mg/dL]), whereas symptom reporting declined. CONCLUSIONS: During mid-life, women experience adverse changes in cardiovascular risk factors and a temporary increase in total number of reported symptoms, with no change in depression. Preventive efforts to reduce the menopause-induced increase in cardiovascular risk factors should begin early in the menopausal transition.
Authors: J T Bromberger; P M Meyer; H M Kravitz; B Sommer; A Cordal; L Powell; P A Ganz; K Sutton-Tyrrell Journal: Am J Public Health Date: 2001-09 Impact factor: 9.308
Authors: Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke Journal: J Clin Endocrinol Metab Date: 2016-07-11 Impact factor: 5.958
Authors: Joyce T Bromberger; Laura L Schott; Nancy E Avis; Sybil L Crawford; Sioban D Harlow; Hadine Joffe; Howard M Kravitz; Karen A Matthews Journal: Psychol Med Date: 2018-04-06 Impact factor: 7.723
Authors: Erin S LeBlanc; Haley Hedlin; FeiFei Qin; Manisha Desai; Jean Wactawski-Wende; Nancy Perrin; JoAnn E Manson; Karen C Johnson; Kamal Masaki; Frances A Tylavsky; Marcia L Stefanick Journal: Maturitas Date: 2015-06-01 Impact factor: 4.342
Authors: Ellen B Gold; John P Pierce; Loki Natarajan; Marcia L Stefanick; Gail A Laughlin; Bette J Caan; Shirley W Flatt; Jennifer A Emond; Nazmus Saquib; Lisa Madlensky; Sheila Kealey; Linda Wasserman; Cynthia A Thomson; Cheryl L Rock; Barbara A Parker; Njeri Karanja; Vicky Jones; Richard A Hajek; Minya Pu; Joanne E Mortimer Journal: J Clin Oncol Date: 2008-12-15 Impact factor: 44.544
Authors: Wayne A Bardwell; Jacqueline M Major; Cheryl L Rock; Vicky A Newman; Cynthia A Thomson; Janice A Chilton; Joel E Dimsdale; John P Pierce Journal: Psychooncology Date: 2004-09 Impact factor: 3.894